RARE: Ultragenyx Corp Revenue Growth QoQ

Graphic logo of ultragenyx.com (RARE)

Ultragenyx Pharmaceutical specializes in therapies for rare genetic pathologies. The QoQ revenue growth percentage illustrates a strategy of minimizing capital expenditures by outsourcing production to third-party CMOs. Diversified international supply chains ensure the preservation of high-value drugs. Contract marketing and outsourced trials accelerate the implementation of innovations. The value of 7.90 shows the current level of this metric.

RARE (Ultragenyx Pharmaceutical Inc.) Quarterly Revenue Increase history from 07/04/2022 to 11/21/2026

Analytical breakdowns for Ultragenyx Pharmaceutical Inc. (RARE)

Initial company analysis:Ultragenyx Corp (RARE)
Mass-produced product of Ultragenyx

This indicator measures the dynamics of quarterly inflows, neutralizing market volatility to identify the actual expansion rates of the operating cash flow. The current quarterly revenue growth rate 7.90 allows investors to assess the effectiveness of the commercial rollout of drugs for rare pathologies and confirm the sustainability of the portfolio scaling strategy of Ultragenyx Pharmaceutical (RARE) during the stage of active market niche capture.

Competitors of Ultragenyx Pharmaceutical (RARE)

TEM - Revenue Growth QoQ|Quarterly Sales Growth Rate qiagen.com QGEN|IONS: Quarterly Revenue Growth|Repligen Corp - Quarterly Revenue Increase|RNA (Avidity Corp) - Quarterly Revenue Growth|CRISPR Therapeutics Corp - Revenue Dynamics QoQ|Revenue Growth QoQ genedx.com (WGS)|Sales Change QoQ BEAM|Quarterly Revenue Growth SRPT (Sarepta Corp)|TWST - Quarterly Sales Growth|TXG: Quarterly Sales Growth|Quarterly Revenue Growth Rate Intellia Therapeutics|STOK: Quarterly Revenue Growth|BLFS - Quarterly Sales Growth Rate|Quarterly Sales Growth WVE|MAZE: Quarterly Revenue Increase|Revenue Growth QoQ Sionna Corp (SION)|Quarterly Sales Growth Rate Prime Medicine Bio|Quarterly Revenue Growth TSHA (Taysha Gene Therapies Inc)|Quarterly Revenue Growth uniqure.com QURE|MeiraGTx Holdings - Quarterly Revenue Growth|RGNX - Quarterly Revenue Growth|SLDB (Solid Corp) - Quarterly Sales Growth|Revenue Change vs Previous Quarter Ocugen Corp OCGN|PACB (Pacific Biosciences) - Quarterly Revenue Growth|Revenue Growth QoQ BNTC|Quarterly Revenue Growth DSGN|Quarterly Sales Growth Rocket Pharma RCKT|Quarterly Sales Growth Rate FDMT|Quarterly Revenue Growth Lexeo Therapeutics LXEO|KRRO - Revenue Growth QoQ|EDIT (Editas Medicine, Inc.) - Sales Growth QoQ|SLN: Quarterly Revenue Growth|ProQR - Quarterly Revenue Increase|CDXS (Codexis) - Quarterly Revenue Growth|Sangamo (SGMO) - Quarterly Sales Growth Rate|Quarterly Revenue Growth NAUT|Quarterly Sales Growth Metagenomi, Inc. MGX|Revenue Growth QoQ Precision BioSciences DTIL|Quarterly Revenue Increase GBIO|BOLD - Revenue Growth QoQ|Quarterly Sales Growth Rate Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Revenue Growth QoQ|RXi Pharmaceuticals - Quarterly Revenue Increase|MBIO (Mustang Bio) - Quarterly Revenue Growth|Sales Growth QoQ RNAZ (transcodetherapeutics.com)|Revenue Growth QoQ Bionano (BNGO)|Applied DNA Sciences - Sales Growth QoQ|Quarterly Revenue Growth BLUE (bluebirdbio.com)|ImmunoPrecise Antibodies (IPA) - Quarterly Revenue Growth Rate|omegatherapeutics.com - Quarterly Revenue Growth|Revenue Change vs Previous Quarter Singular Genomics Systems Inc (OMIC)|RGLS: Quarterly Revenue Growth|Syros Pharmaceuticals, Inc (SYRS) - Quarterly Revenue Growth|TBIO (telesisbio.com) - Quarterly Revenue Growth|TCON: Quarterly Revenue Increase|Revenue Growth QoQ Unity Biotechnology, Inc (UBX)